Effect of sodium orthovanadate on the hepatobiliary clearance of rose bengal in streptozotocin-induced diabetic rats

John B. Watkins, Mark E. Bauman, Timothy M. Beaty

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Sodium orthovanadate is known to promote glucose uptake in muscle and adipose tissues and has been suggested as a possible oral hypoglycemic agent. In addition, insulin-dependent diabetes has been shown to alter the hepatobiliary clearance of several drugs in rats. This study has determined whether orthovanadate, like insulin, can reverse diabetes-induced changes in the biliary excretion of endogenous bile acids and in the hepatobiliary clearance of rose bengal. Six groups of male Sprague-Dawley rats were used: normal, insulin-treated normal, vanadate-treated normal, diabetic, insulin-treated diabetic, and vanadate-treated diabetic. Diabetes was induced by injection of streptozotocin (45 mg/kg, i.v.). One week later, insulin (2-4 U/day, s.c.) and sodium orthovanadate (877 ± 82 μmol/kg/day, p.o.) treatments were initiated. After 4 weeks, the clearance and biliary excretion of rose bengal (60 μmol/kg, i.v.) were determined for 3 hr. Bile flow rate, rose bengal excretion, and excretion of endogenous bile acids were unchanged in the two treated normal groups inthe insulin-treated diabetic rats. These parameters were increased in untreated diabetic and vanadate-treated diabetic rats as compared with normal. Pharmacokinetic analyses indicated that total and biliary clearances of rose bengal were increased in diabetic rats and orthovanadate did not reverse these changes. However, liver weight and serum glucose concentrations were reduced by orthovanadate treatment. These data indicate that the oral insulinomimeric chemical sodium orthovanadate effectively reversed some, but not all, of the diabetes-induced alterations of hepatic function.

Original languageEnglish
Pages (from-to)2269-2276
Number of pages8
JournalBiochemical Pharmacology
Volume46
Issue number12
DOIs
StatePublished - Dec 14 1993

Fingerprint

Rose Bengal
Vanadates
Streptozocin
Rats
Sodium
Insulin
Medical problems
Bile Acids and Salts
Glucose
Pharmacokinetics
Liver
Hypoglycemic Agents
Bile
Sprague Dawley Rats
Muscle
Adipose Tissue
Flow rate
Tissue
Weights and Measures
Muscles

Keywords

  • bile acids
  • bile production
  • biliary excretion
  • clearance, hepatobiliary
  • diabetes, insulin-dependent
  • orthovanadate, sodium
  • pharmacokinetics
  • rose bengal
  • streptozotocin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effect of sodium orthovanadate on the hepatobiliary clearance of rose bengal in streptozotocin-induced diabetic rats. / Watkins, John B.; Bauman, Mark E.; Beaty, Timothy M.

In: Biochemical Pharmacology, Vol. 46, No. 12, 14.12.1993, p. 2269-2276.

Research output: Contribution to journalArticle

Watkins, John B. ; Bauman, Mark E. ; Beaty, Timothy M. / Effect of sodium orthovanadate on the hepatobiliary clearance of rose bengal in streptozotocin-induced diabetic rats. In: Biochemical Pharmacology. 1993 ; Vol. 46, No. 12. pp. 2269-2276.
@article{553ef77e6e6f44f5b4fd0e4fa07a8720,
title = "Effect of sodium orthovanadate on the hepatobiliary clearance of rose bengal in streptozotocin-induced diabetic rats",
abstract = "Sodium orthovanadate is known to promote glucose uptake in muscle and adipose tissues and has been suggested as a possible oral hypoglycemic agent. In addition, insulin-dependent diabetes has been shown to alter the hepatobiliary clearance of several drugs in rats. This study has determined whether orthovanadate, like insulin, can reverse diabetes-induced changes in the biliary excretion of endogenous bile acids and in the hepatobiliary clearance of rose bengal. Six groups of male Sprague-Dawley rats were used: normal, insulin-treated normal, vanadate-treated normal, diabetic, insulin-treated diabetic, and vanadate-treated diabetic. Diabetes was induced by injection of streptozotocin (45 mg/kg, i.v.). One week later, insulin (2-4 U/day, s.c.) and sodium orthovanadate (877 ± 82 μmol/kg/day, p.o.) treatments were initiated. After 4 weeks, the clearance and biliary excretion of rose bengal (60 μmol/kg, i.v.) were determined for 3 hr. Bile flow rate, rose bengal excretion, and excretion of endogenous bile acids were unchanged in the two treated normal groups inthe insulin-treated diabetic rats. These parameters were increased in untreated diabetic and vanadate-treated diabetic rats as compared with normal. Pharmacokinetic analyses indicated that total and biliary clearances of rose bengal were increased in diabetic rats and orthovanadate did not reverse these changes. However, liver weight and serum glucose concentrations were reduced by orthovanadate treatment. These data indicate that the oral insulinomimeric chemical sodium orthovanadate effectively reversed some, but not all, of the diabetes-induced alterations of hepatic function.",
keywords = "bile acids, bile production, biliary excretion, clearance, hepatobiliary, diabetes, insulin-dependent, orthovanadate, sodium, pharmacokinetics, rose bengal, streptozotocin",
author = "Watkins, {John B.} and Bauman, {Mark E.} and Beaty, {Timothy M.}",
year = "1993",
month = "12",
day = "14",
doi = "10.1016/0006-2952(93)90617-6",
language = "English",
volume = "46",
pages = "2269--2276",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Effect of sodium orthovanadate on the hepatobiliary clearance of rose bengal in streptozotocin-induced diabetic rats

AU - Watkins, John B.

AU - Bauman, Mark E.

AU - Beaty, Timothy M.

PY - 1993/12/14

Y1 - 1993/12/14

N2 - Sodium orthovanadate is known to promote glucose uptake in muscle and adipose tissues and has been suggested as a possible oral hypoglycemic agent. In addition, insulin-dependent diabetes has been shown to alter the hepatobiliary clearance of several drugs in rats. This study has determined whether orthovanadate, like insulin, can reverse diabetes-induced changes in the biliary excretion of endogenous bile acids and in the hepatobiliary clearance of rose bengal. Six groups of male Sprague-Dawley rats were used: normal, insulin-treated normal, vanadate-treated normal, diabetic, insulin-treated diabetic, and vanadate-treated diabetic. Diabetes was induced by injection of streptozotocin (45 mg/kg, i.v.). One week later, insulin (2-4 U/day, s.c.) and sodium orthovanadate (877 ± 82 μmol/kg/day, p.o.) treatments were initiated. After 4 weeks, the clearance and biliary excretion of rose bengal (60 μmol/kg, i.v.) were determined for 3 hr. Bile flow rate, rose bengal excretion, and excretion of endogenous bile acids were unchanged in the two treated normal groups inthe insulin-treated diabetic rats. These parameters were increased in untreated diabetic and vanadate-treated diabetic rats as compared with normal. Pharmacokinetic analyses indicated that total and biliary clearances of rose bengal were increased in diabetic rats and orthovanadate did not reverse these changes. However, liver weight and serum glucose concentrations were reduced by orthovanadate treatment. These data indicate that the oral insulinomimeric chemical sodium orthovanadate effectively reversed some, but not all, of the diabetes-induced alterations of hepatic function.

AB - Sodium orthovanadate is known to promote glucose uptake in muscle and adipose tissues and has been suggested as a possible oral hypoglycemic agent. In addition, insulin-dependent diabetes has been shown to alter the hepatobiliary clearance of several drugs in rats. This study has determined whether orthovanadate, like insulin, can reverse diabetes-induced changes in the biliary excretion of endogenous bile acids and in the hepatobiliary clearance of rose bengal. Six groups of male Sprague-Dawley rats were used: normal, insulin-treated normal, vanadate-treated normal, diabetic, insulin-treated diabetic, and vanadate-treated diabetic. Diabetes was induced by injection of streptozotocin (45 mg/kg, i.v.). One week later, insulin (2-4 U/day, s.c.) and sodium orthovanadate (877 ± 82 μmol/kg/day, p.o.) treatments were initiated. After 4 weeks, the clearance and biliary excretion of rose bengal (60 μmol/kg, i.v.) were determined for 3 hr. Bile flow rate, rose bengal excretion, and excretion of endogenous bile acids were unchanged in the two treated normal groups inthe insulin-treated diabetic rats. These parameters were increased in untreated diabetic and vanadate-treated diabetic rats as compared with normal. Pharmacokinetic analyses indicated that total and biliary clearances of rose bengal were increased in diabetic rats and orthovanadate did not reverse these changes. However, liver weight and serum glucose concentrations were reduced by orthovanadate treatment. These data indicate that the oral insulinomimeric chemical sodium orthovanadate effectively reversed some, but not all, of the diabetes-induced alterations of hepatic function.

KW - bile acids

KW - bile production

KW - biliary excretion

KW - clearance, hepatobiliary

KW - diabetes, insulin-dependent

KW - orthovanadate, sodium

KW - pharmacokinetics

KW - rose bengal

KW - streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=0027135996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027135996&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(93)90617-6

DO - 10.1016/0006-2952(93)90617-6

M3 - Article

VL - 46

SP - 2269

EP - 2276

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -